Human Normal Immunoglobulin bulk supplier for pharma manufacturers

Human Normal Immunoglobulin Suppliers & Bulk Manufacturers

Available Forms: (IVIG) & (SCIG)

Available Strengths: IVIG: 5%, 10%, 16%, 20%; SCIG: 20%

Reference Brands: Privigen®, Gamunex-C® (EU & US)

Category: Hepatitis

Human Normal Immunoglobulin is available in (IVIG) & (SCIG) and strengths such as IVIG: 5%, 10%, 16%, 20%; SCIG: 20%. Sourced from GMP-certified and ISO-compliant manufacturers, this API meets global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical formulation and commercial manufacturing, Human Normal Immunoglobulin is supplied in bulk quantities with complete regulatory support including DMF, COA, and MSDS.

Technical Specifications & Supply Details
Lead Time 7 to 60 days (depending on batch size & schedule)
MOQ As per manufacturer’s batch size
COA Available with every batch
Regulatory Dossier / DMF Available upon request
Export Documentation FSC, COA, Manufacturing License, Product Permission
Standards IP, BP, USP
Certifications WHO-GMP, EU-GMP, USFDA (as applicable)

Human Normal Immunoglobulin can be exported to over 30 countries across Asia, Africa, Europe, and Latin America. Flexible packaging, competitive pricing, and a verified supplier network make Pharmatradz a trusted sourcing partner for pharmaceutical companies and contract manufacturers worldwide.

Get Enquiry / Request Bulk Quote

Quick Response Guaranteed | Verified Suppliers

📘 Sourcing Guide
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'

The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing

Product Description: Human Normal Immunoglobulin Injection is a sterile, purified preparation of pooled human plasma antibodies used for passive immunization and immune support. It treats immunodeficiency disorders, autoimmune diseases, and certain infections by providing broad-spectrum antibodies. Available as intravenous (IVIG) or subcutaneous (SCIG) formulations with concentrations typically ranging from 5% to 20%. Manufactured under stringent EU-GMP and USFDA standards, it is ideal for hospital supply, tender bids, and B2B partnerships. Complete regulatory dossiers and batch-release documentation support rapid registration and distribution in global and regulated markets.

Frequently Asked Questions

Yes, Human Normal Immunoglobulin is available with DMF and other regulatory documents such as COA and MSDS. These can be provided upon request for qualified buyers.

Absolutely. Sample requests are accepted for formulation trials and quality checks. Please submit an enquiry to initiate the process.

Our manufacturing partners are GMP-certified and comply with ISO and WHO standards, ensuring global quality benchmarks.

Lead times vary based on quantity and destination, but most orders are fulfilled within 1–3 weeks. Express shipping options are available.

Yes, Human Normal Immunoglobulin is exported to over 30 countries across Asia, Africa, Europe, and Latin America. We support documentation for customs and regulatory clearance.

Related Products

Ombitasvir/Paritaprevir/Ritonavir + Dasabuvir

Strength: Ombitasvir 12.5 mg / Paritaprevir 75 mg / Ritonavir 50 mg (tablet)+ Dasabuvir 250 mg (tablet)

Form: Tablet

Reference Brands: Viekira Pak® (US); Viekirax® + Exviera® (EU)

View Details
Glecaprevir/Pibrentasvir

Strength: Glecaprevir 100 mg Pibrentasvir 40 mg

Form: Oral tablets

Reference Brands: Mavyret®

View Details
Ribavirin

Strength: Tablet:200 mg, 400 mg, 600mg; Capsule:200 mg; Solution:40 mg/mL

Form: Tablets, Capsules and Oral Solution

Reference Brands: Rebetol®, Copegus®, Virazole®(EU & US)

View Details
Adefovir Dipivoxil

Strength: 10 mg

Form: Oral tablets

Reference Brands: Hepsera® (EU & US)

View Details
Enquire Now

Quick Response Guaranteed | Verified Suppliers

Subscribe to Our Newsletter

Stay updated on pharma trends and marketplace opportunities.

Please enter the correct answer.
This website uses cookies to ensure you get the best experience. By using our site, you agree to our Privacy Policy.